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Background: Increasing nut intake has been associated with reduced risk of diabetes mellitus, which is a risk factor for pancreatic
cancer.
Methods: We prospectively followed 75680 women in the Nurses’ Health Study, and examined the association between nut
consumption and pancreatic cancer risk. Participants with a previous history of cancer were excluded. Nut consumption was
assessed at baseline and updated every 2 to 4 years. Relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated
using Cox proportional hazards models.
Results: We documented 466 incident cases of pancreatic cancer. After adjusting for age, height, smoking, physical activity, and
total energy intake, women who consumed a 28-g (1oz) serving size of nuts X2 times per week experienced a significantly lower
risk of pancreatic cancer (RR, 0.65; 95% CI, 0.47–0.92; P for trend¼0.007) when compared with those who largely abstained from
nuts. The results did not appreciably change after further adjustment for body mass index (BMI) and history of diabetes mellitus
(RR, 0.68; 95% CI, 0.48–0.95; P for trend¼0.01). The inverse association persisted within strata defined by BMI, physical activity,
smoking, and intakes of red meat, fruits, and vegetables.
Conclusion: Frequent nut consumption is inversely associated with risk of pancreatic cancer in this large prospective cohort of
women, independent of other potential risk factors for pancreatic cancer.
Pancreatic cancer is among the most fatal malignancies, represent-
ing the fourth most common cause for cancer-related mortality in
the United States (Jemal et al, 2010). Primary prevention remains
the most feasible approach to reducing the incidence of pancreatic
cancer, which makes the identification of modifiable risk factors
essential. Unfortunately, very few modifiable risk factors have been
identified. The 2009 World Cancer Research Fund/American
Institute for Cancer Research (WCRF/AICR) report concluded
that, beyond cigarette smoking, body fatness was the only
convincing modifiable risk factor for pancreatic cancer (WCRF/
AICR, 2009).
Extensive evidence suggests that common states of insulin
resistance such as obesity (Larsson et al, 2007) are associated with
an increased risk of pancreatic cancer – possibly mediated through
chronic hyperglycaemia and hyperinsulinaemia. Type II diabetes
mellitus, a potential consequence of pancreatic cancer, is also a risk
factor for this fatal disease (Everhart and Wright, 1995; Elena et al,
2013). Recent studies demonstrate that elevated baseline plasma
insulin and C-peptide significantly increased subsequent pancreatic
cancer risk (Stolzenberg-Solomon et al, 2005; Michaud et al, 2007).
Nuts are a rich source of bioactive components such as unsaturated
fatty acids, fibre, and magnesium (Brufau et al, 2006), which may
improve insulin sensitivity (Anderson et al, 1987; Paolisso et al,
1989; Riserus et al, 2009). Data from the National Health
and Nutrition Examination Survey (NHANES) found that
nut consumption was associated with decreased insulin levels
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and metabolic syndrome (O’Neil et al, 2011). Prospective
epidemiologic data have further shown that regular nut consump-
tion is associated with lower risk of type II diabetes (Jiang et al,
2002; Villegas et al, 2008). Because diabetes is a consistent risk
factor for pancreatic cancer, and insulin resistance is an important
underlying mechanism (Giovannucci and Michaud, 2007), we
investigated prospectively the association between nut consump-
tion and risk of pancreatic cancer in a large cohort of women in the
Nurses’ Health Study (NHS).
MATERIALS AND METHODS
Study population. The NHS began in 1976 when 121700 US
female nurses aged 30–55 years returned the initial questionnaire.
In 1980, the questionnaire was expanded to include a validated
semiquantitative food frequency questionnaire (Willett et al, 1985).
Follow-up questionnaires were sent to participants every 2 years to
update information on new disease diagnoses and potential
risk factors for chronic diseases. The overall follow-up rate
exceeded 90%.
For the present analysis, follow-up started in 1980 when dietary
information was first assessed. At baseline, 92468 women
completed the dietary questionnaire. We excluded 3670 women
who had a history of cancer, 1141 women who did not provide
information on nut intake, and 11977 women who did not provide
information on anthropometric measures or physical activity, or
reported implausible nutritional information (49 missing food
items or estimated daily energy intake o500kcal or 43500kcal).
After these exclusions, 75680 women were eligible for the analyses.
This study was approved by the Human Research Committee at
the Brigham and Women’s Hospital.
Dietary assessment. Dietary intake was obtained from the NHS
participants via validated semiquantitative food frequency ques-
tionnaires in 1980, 1984, 1986, and every 4 years thereafter.
Participants were asked to report their average frequency of intake
over the preceding year for a specified serving size of each food.
Individual nutrient intakes (e.g., vitamin D intake) were calculated
by multiplying the frequency of each food consumed by the
nutrient content of the specified portion size and then summing
the contributions from all foods.
In the 1980 and 1984 dietary questionnaires, we asked the
participants how often, on average, they had consumed nuts
(peanut butter not included; serving size, 28g (1oz)) over the
preceding year: never/almost never, 1 to 3 times a month, once a
week, 2 to 4 times a week, 5 to 6 times a week, once a day, 2 to 3
times a day, 4 to 6 times a day, or more than 6 times a day. In the
1986, 1990, 1994, 1998, 2002, and 2006 dietary questionnaires, the
question for nuts was split into two items: peanuts and other nuts.
Total nut consumption was the sum of peanuts and other nuts
intake. A validation study of the food frequency questionnaires in
the NHS indicated that nut intake was reported with reasonable
accuracy; the correlation coefficient was 0.75 between nut intakes
assessed by the 1980 questionnaire and by dietary records collected
over 4 weeks (Salvini et al, 1989).
Identification of pancreatic cancer cases. Participants were asked
to report specified medical conditions, including cancers, that were
diagnosed in the 2-year period between each follow-up ques-
tionnaire. Whenever a participant (or next of kin for decedents)
reported a diagnosis of pancreatic cancer, we asked for permission
to obtain the participant’s medical records. We also searched the
National Death Index to identify deaths among nonrespondents.
This method has been shown to capture 498% of deaths
(Rich-Edwards et al, 1994). If the primary cause of death on the
death certificate was a previously unreported pancreatic cancer
case, we contacted a family member to obtain permission to
retrieve medical records. Study physicians who were blinded to
participants’ risk factor status reviewed medical records and
assigned cancer diagnoses and causes of death. In the NHS cohort,
all medical records had complete information on histology
(hospitals were recontacted if the original information sent was
incomplete). We were able to obtain pathology reports confirming
the diagnosis of pancreatic cancer for 91% of cases. For the other
9% of cases, we obtained confirmation of the self-reported cancer
from a secondary source (e.g., death certificate, physician, or
telephone interview of a family member). In our analyses,
associations were examined including and excluding cases
confirmed by secondary sources; because no differences were
observed between these two types of analyses, we included cases
confirmed by secondary sources.
Assessment of nondietary factors. At baseline and in all
subsequent questionnaires, women were asked about their history
of active smoking, including smoking status, time since quitting,
and average number of cigarettes smoked daily. Information on
physical activity was assessed at baseline and updated every 2 to
4 years. Body mass index (BMI) was calculated from height self-
reported at baseline and weight updated every 2 years. Because
pancreatic cancer is frequently associated with profound weight
loss, we added a 4-year lag period when we updated BMI during
follow-up, that is, we used BMI data from the 1976 questionnaire
for the follow-up period from 1980 to 1982, 1978 for the interval
from 1982 to 1984, 1980 for the interval from 1984 to 1986, and so
forth.
Statistical analysis. We computed person-time from the return
date of the 1980 questionnaire to the date of pancreatic cancer
diagnosis, death from any cause, or the end of follow-up (30 June
2010), whichever came first. We calculated the cumulative average
of dietary factors from all dietary questionnaires, using methods for
repeated measures described previously (Hu et al, 1997). Briefly,
we used data from the 1980 questionnaire for the follow-up period
from 1980 to 1984, the average of 1980 and 1984 for the interval
from 1984 to 1986, and the average of 1980, 1984, and 1986 for the
interval from 1986 to 1990, and so forth. For analysis of total nuts,
we divided women into four categories according to their
frequency of nut consumption: never/almost never (the reference
group), 1 to 3 times a month, once a week, and at least 2 times a
week. For separate analysis of peanuts and other nuts, we divided
women into three categories: never/almost never (the reference
group), 1 to 3 times a month, and at least once a week. Relative
risks (RRs) and 95% confidence intervals (CIs) were estimated by
Cox proportional hazards models.
In multivariate analyses, we adjusted for potential confounding
variables including age, height (quintiles), physical activity
(quintiles), smoking (never; past; current 1–14 pack-years; current
15–24 pack-years; current X25 pack-years), and total energy
intake. We then adjusted for BMI (quintiles) and diabetes (yes/no),
to see if the observed association was independent of these
potential mediators or confounding factors for the association
between nut intake and pancreatic cancer risk. We further adjusted
for dietary factors including alcohol (never, 0.1–4.9, 5–14.9, and
X15gday
 1), multivitamin use (yes/no), and intakes of red meat,
fruits, and vegetables, and vitamin D (quintiles). As nut is often
considered a component of the Mediterranean dietary pattern
and a recent study showed an inverse association between
the Mediterranean diet and pancreatic cancer risk (Bosetti et al,
2013), we additionally adjusted for a Mediterranean diet score
(Trichopoulou et al, 2003) in a sensitivity analysis to examine
whether the association with nuts is independent of the
Mediterranean dietary pattern. The P-values for trend were
calculated by the Wald test of a score variable that contained
median values of intake categories.
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analysis excluding individuals with diabetes. To rule out any effect
of subclinical pancreatic cancer on nut intake, we performed an
additional analysis in which we added a 4-year lag period between
nut intake assessment and each follow-up period (follow-up started
in 1984 for this analysis), that is, we used nut intake from the 1980
questionnaire for the follow-up period from 1984 to 1988, the
cumulative average of nut intake in 1980–1984 for the interval
from 1988 to 1992, and so forth.
To examine whether the association between nut intake and risk
of pancreatic cancer was modified by other factors, we examined
the association in subgroups defined by BMI, physical activity,
smoking status, and intakes of red meat, fruits, and vegetables.
Tests for interaction were performed by the Wald test of cross-
product terms. All statistical analyses were performed with the
SAS 9.1 statistical package (SAS Institute, Cary, NC,, USA) and all
P-values are two sided.
RESULTS
During study follow-up, nut consumption remained relatively
constant. Women with more frequent nut consumption were
generally leaner, more likely to exercise, and less likely to smoke
(Table 1). They also tended to consume more alcohol, multi-
vitamin supplements, and fruits and vegetables.
During 2112234 person-years of follow up from 1980 to 2010,
we documented 466 confirmed incident cases of pancreatic cancer.
Frequency of nut consumption was inversely associated with risk
of pancreatic cancer (Table 2). Compared with women who largely
abstained, participants who consumed a 28-g (1oz) serving size of
nuts X2 times per week experienced an age-adjusted RR of
pancreatic cancer of 0.65 (95% CI, 0.47–0.90; P for trend¼0.005)
and a multivariate RR of 0.65 (95% CI, 0.47–0.92; P for
trend¼0.007). The RR did not appreciably change after control-
ling for BMI and history of diabetes (RR, 0.68; 95% CI, 0.48–0.95;
P for trend¼0.01). Further controlling for dietary variables,
including alcohol, multivitamin use, and intakes of red meat, fruits,
and vegetables, and vitamin D, yielded similar results (multivariate
RR, 0.68; 95% CI, 0.48–0.96; P for trend¼0.01).
The results also remained the same when we adjusted for
the Mediterranean diet score (multivariate RR, 0.65; 95% CI,
0.46–0.92; P for trend¼0.008).
We considered the possibility that occult pancreatic cancer in
the years that preceded diagnosis may be have influenced dietary
patterns. However, our findings remained essentially unchanged
after we added a 4-year lag period between nut intake assessment
and each follow-up period (multivariate RR, 0.73; 95% CI,
0.52–1.03, comparing X2 times/week with never/almost never;
P for trend¼0.03). Moreover, our results remained consistent after
excluding women with a history of diabetes mellitus (multivariate
RR, 0.67; 95% CI, 0.46–0.96, comparing X2 times/week with
never/almost never; P for trend¼0.02).
To examine further the independent association with nut
consumption, we repeated the multivariate analyses within
subgroups of BMI, physical activity, smoking, and intakes of red
meat, fruits, and vegetables (Table 3). An inverse association
persisted in all subgroups, and we found no apparent modification
of the relation between nut consumption and pancreatic cancer
risk by these factors.
In analyses of peanuts and other nuts (assessed in 1986)
separately, peanuts and other nuts were both inversely associated
with risk of pancreatic cancer, although the associations were not
statistically significant. The multivariate RRs comparing X2 times/
week with never/almost never are 0.89 (95% CI, 0.57–1.39; 27
cases) for peanuts and 0.63 (95% CI, 0.39–1.03; 20 cases) for other
nuts (Pheterogeneity¼0.30).
DISCUSSION
In this large prospective cohort of women, frequent nut
consumption was associated with a significantly reduced risk of
pancreatic cancer, independent of established or suspected risk
factors for pancreatic cancer including age, height, obesity, physical
activity, smoking, diabetes, and dietary factors. Women who
consumed a 28-g (1oz) serving size of nuts X2 times per week had
a significantly lower risk of pancreatic cancer, and the inverse
association persisted in all subgroup analyses.
To our knowledge, this represents the first study to prospec-
tively assess the association between nut consumption and
pancreatic cancer risk. Although a previous case–control study
found no association between combined intake of ‘nut and tasty
snacks’ and risk of pancreatic cancer, the analysis was limited by its
retrospective design, use of proxy next-of-kin respondents,
assessment of diet within 1 year of diagnosis, and lack of data on
nut intake exclusive of other snack foods (Bueno de Mesquita et al,
1991).
To date, no specific dietary factor or nutrient has been
conclusively associated with the risk of pancreatic cancer
(WCRF/AICR, 2009). Nut consumption could influence pancreatic
cancer risk through several potential mechanisms, most notably
Table 1. Characteristics of person-years by nut consumption
a
















0 0.01–0.09 0.10–0.19 X0.20
Person-years 364282 971411 388832 387709
Age, years, mean
(s.d.)
55.8 (10.9) 59.6 (10.9) 60.3 (10.8) 60.9 (10.8)
Height, inches,
mean (s.d.)
64.4 (2.4) 64.5 (2.4) 64.6 (2.4) 64.6 (2.4)
Body mass index,
kgm
 2, mean (s.d.)





13.8(20.4) 15.7(21.0) 17.4(22.1) 19.5(25.1)
Current smoking, % 20.7 15.3 13.8 13.5
History of diabetes
mellitus, %
7.8 7.1 6.6 6.0
Multivitamin use, % 32.5 42.6 46.5 49.9
Alcohol intake,
gday
 1, mean (s.d.)
5.2 (9.4) 5.6 (9.0) 6.6 (9.4) 7.4 (10.2)
Red meat, servings
per day, mean (s.d.)




2.3 (1.2) 2.6 (1.2) 2.8 (1.2) 3.0 (1.3)
Fruits, servings per
day, mean (s.d.)
2.0 (1.2) 2.1 (1.1) 2.3 (1.2) 2.5 (1.3)
aAll variables (except age) are age standardised.
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tional studies have reported increased risk of pancreatic cancer
among subjects with higher circulating insulin (Stolzenberg-
Solomon et al, 2005) or C-peptide (Michaud et al, 2007) and
among those with a history of type II diabetes (Everhart and
Wright, 1995; Elena et al, 2013). Concurrently, studies have found
that increasing nut intake was associated with decreased insulin
levels (Estruch et al, 2006; Jenkins et al, 2006; Tapsell et al, 2009;
Casas-Agustench et al, 2011b; O’Neil et al, 2012) and lower risk of
developing metabolic syndrome (Salas-Salvado et al, 2008;
Fernandez-Montero et al, 2013). Furthermore, some (Jiang et al,
2002; Villegas et al, 2008), though not all (Parker et al, 2003),
prospective studies have shown that regular nut consumption was
inversely associated with the risk of type II diabetes mellitus. In a
previous analysis of this same cohort, higher nut consumption was
associated with lower risk of type II diabetes (multivariate RR
comparing X5 times per week with almost never¼0.73; 95% CI,
0.60–0.89; P for trendo0.001) (Jiang et al, 2002). Similarly, a
Table 2. Relative risks (RRs) and 95% confidence intervals (CIs) for pancreatic cancer according to nut consumption
Frequency of nut consumption (28g serving)
Never/almost never 1–3 Times per month Once per week X2 Times per week Ptrend
Nut intake, servings per day 0 0.01–0.09 0.10–0.19 X0.20
Cases 75 236 78 77
Person-years 364282 971411 388832 387709
Age adjusted 1.00 0.85 (0.65–1.10) 0.67 (0.49–0.93) 0.65 (0.47–0.90) 0.005
Multivariate I
a 1.00 0.86 (0.66–1.13) 0.68 (0.49–0.94) 0.65 (0.47–0.92) 0.007
Multivariate II
b 1.00 0.87 (0.67–1.14) 0.70 (0.50–0.97) 0.68 (0.48–0.95) 0.01
Multivariate III
c 1.00 0.90 (0.69–1.18) 0.71 (0.51–0.99) 0.68 (0.48–0.96) 0.01
aAdjusted for age, height (quintiles), physical activity (quintiles), smoking (never; past; current 1–14 pack-years; current 15–24 pack-years; current X25 pack-years), and total energy intake.
bMultivariate Iþbody mass index (BMI; quintiles) and history of diabetes mellitus (yes/no).
cMultivariate IIþdietary variables including alcohol (never, 0.1–4.9, 5–14.9, and X15gday
 1), multivitamin use (yes/no), and intakes of red meat, fruits and vegetables, and vitamin D (quintiles).
Table 3. Multivariate relative risks (RRs) and 95% confidence intervals (CIs) for pancreatic cancer according to nut consumption, stratified by risk factors
a












Nut intake, servings per day 0 0.01–0.09 0.10–0.19 X0.20
Body mass index 0.26
o25kgm
 2 201 1160296 1.00 0.93 (0.61–1.42) 0.75 (0.45–1.24) 0.86 (0.53–1.41) 0.50
X25kgm




236 1148936 1.00 1.17 (0.76–1.80) 1.03 (0.63–1.70) 0.80 (0.47–1.34) 0.09
49.5 Metabolic equivalents
per week
230 963298 1.00 0.70 (0.50–0.99) 0.49 (0.31–0.78) 0.61 (0.39–0.96) 0.05
Smoking 0.76
Never 188 960486 1.00 0.76 (0.50–1.15) 0.65 (0.39–1.08) 0.54 (0.32–0.93) 0.03
Ever 278 1151748 1.00 0.93 (0.66–1.32) 0.71 (0.46–1.09) 0.77 (0.49–1.19) 0.14
Red meat consumption 0.26
p1.0 Servings per day 294 1058710 1.00 1.00 (0.71–1.41) 0.65 (0.42–1.01) 0.70 (0.45–1.08) 0.02
41.0 Servings per day 172 1053524 1.00 0.71 (0.46–1.11) 0.75 (0.45–1.24) 0.64 (0.37–1.09) 0.22
Vegetable consumption 0.30
p2.5 Servings per day 195 1066486 1.00 0.78 (0.89–1.75) 0.51 (0.75–1.79) 0.58 (0.50–1.25) 0.02
42.5 Servings per day 271 1045748 1.00 1.02 (0.67–1.55) 0.88 (0.55–1.40) 0.82 (0.51–1.31) 0.18
Fruit consumption 0.33
p2.0 Servings per day 211 1058444 1.00 0.85 (0.59–1.24) 0.78 (0.48–1.25) 0.78 (0.47–1.29) 0.36
42.0 Servings per day 255 1053790 1.00 0.91 (0.61–1.34) 0.65 (0.41–1.03) 0.62 (0.39–0.98) 0.01
aAdjusted for the same covariates as multivariate II in Table 2.
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association between peanut consumption and risk of type II
diabetes (multivariate RR comparing extreme quintiles¼0.80; 95%
CI, 0.68–0.93; P for trendo0.0001) (Villegas et al, 2008). Although
the underlying mechanisms remain uncertain, nuts are rich in
several nutrients associated with improved insulin sensitivity and
decreased insulin demand and resistance, including unsaturated
fatty acids, fibre, and magnesium (Anderson et al, 1987; Paolisso
et al, 1989; Riserus et al, 2009). It is noteworthy that intakes of
unsaturated fat, fibre, and magnesium were not associated with
pancreatic cancer risk in this (Michaud et al, 2003) or other
cohorts (Stolzenberg-Solomon et al, 2002; Kesavan et al, 2010;
Molina-Montes et al, 2012).
Alternatively, other nutrients and bioactive compounds in
nuts, such as vitamins (e.g., folate, niacin, vitamin E) and phyto-
chemicals (e.g., carotenoids, flavonoids, and phytosterols), may
confer antioxidant, anti-inflammatory, or anticancer properties
(Gonzalez and Salas-Salvado, 2006). Indeed, observational studies
and clinical trials have demonstrated beneficial effects of nuts on
oxidative stress (Jenkins et al, 2006; Torabian et al, 2009) and
inflammatory markers (Jiang et al, 2006). In addition, some studies
reported that high serum a-tocopherol, the biologically active form
of vitamin E, was associated with a reduced risk of pancreatic
cancer (Stolzenberg-Solomon et al, 2009). This evidence supports a
role of nuts in pancreatic cancer prevention.
There may be a concern that frequent nut consumption may
result in weight gain and therefore increase the risk of developing
pancreatic cancer. However, in our cohort, women reporting
greater nut intake tended to weigh less (Table 1). In fact, nut
consumption has been shown to be associated with less weight gain
(Bes-Rastrollo et al, 2007; Bes-Rastrollo et al, 2009; Casas-
Agustench et al, 2011a). A recent analysis of this same cohort
found that higher nut consumption was associated with a slightly
lower risk of weight gain and obesity (Bes-Rastrollo et al, 2009).
The strengths of this study include its prospective design, large
sample size, and 430 years of follow-up. Our validation data
indicate that nut intake was measured reasonably accurately
(Salvini et al, 1989); in addition, we updated nut consumption
repeatedly during follow-up, thereby accounting for true changes
in diet and reducing measurement error. Moreover, as dietary data
were collected prospectively, any misclassification of exposure
should be random, thereby biasing the association towards the null.
Although participants with subclinical pancreatic cancer may have
decreased their nut consumption, the inverse association persisted
when we added a 4-year lag period between nut intake and each
follow-up period.
Our study also has limitations. Although we cannot exclude
residual confounding by other potential risk factors for pancreatic
cancer, our study provided detailed information on the lifestyle and
diet of the participants. In our analysis, we adjusted for BMI,
physical activity, smoking, diabetes history, and other relevant
dietary factors, and the results were virtually unchanged.
In addition, the inverse association persisted across all subgroups
(e.g., subgroups defined by BMI, physical activity, smoking, red
meat, fruits, and vegetables), further suggesting an independent
inverse association. Because our study population is relatively
homogeneous in education and occupation, confounding by
socioeconomic status was minimised. Although we cannot rule
out the possibility of confounding by unknown risk factors, it is
unlikely that it can fully explain the observed modest association
(Flanders and Khoury, 1990).
In conclusion, frequent nut consumption was associated with a
reduced risk of pancreatic cancer in this large prospective cohort
study of women. Although additional confirmatory studies are
warranted, our findings offer potential insights into both the
prevention and biology of this highly fatal and poorly understood
malignancy.
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